1
|
Eckhardt BL, Parker BS, van Laar RK, Restall CM, Natoli AL, Tavaria MD, Stanley KL, Sloan EK, Moseley JM, Anderson RL. Genomic Analysis of a Spontaneous Model of Breast Cancer Metastasis to Bone Reveals a Role for the Extracellular Matrix. Mol Cancer Res 2005. [DOI: 10.1158/1541-7786.1.3.1] [Citation(s) in RCA: 67] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
A clinically relevant model of spontaneous breast cancer metastasis to multiple sites, including bone, was characterized and used to identify genes involved in metastatic progression. The metastatic potential of several genetically related tumor lines was assayed using a novel real-time quantitative RT-PCR assay of tumor burden. Based on this assay, the tumor lines were categorized as nonmetastatic (67NR), weakly metastatic to lymph node (168FARN) or lung (66cl4), or highly metastatic to lymph node, lung, and bone (4T1.2 and 4T1.13). In vitro assays that mimic stages of metastasis showed that highly metastatic tumors lines were more adhesive, invasive, and migratory than the less metastatic lines. To identify metastasis-related genes in this model, each metastatic tumor was array profiled against the nonmetastatic 67NR using 15,000 mouse cDNA arrays. A significant proportion of genes relating to the extracellular matrix had elevated expression in highly metastatic tumors. The role of one of these genes, POEM, was further investigated in the model. In situ hybridization showed that POEM expression was specific to the tumor epithelium of highly metastatic tumors. Decreased POEM expression in 4T1.2 tumors significantly inhibited spontaneous metastasis to the lung, bone, and kidney. Taken together, our data support a role for the extracellular matrix in metastatic progression and describe, for the first time, a role for POEM in this process.
Collapse
Affiliation(s)
- Bedrich L. Eckhardt
- 1Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria, Australia and
| | - Belinda S. Parker
- 1Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria, Australia and
| | - Ryan K. van Laar
- 1Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria, Australia and
| | - Christina M. Restall
- 1Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria, Australia and
| | - Anthony L. Natoli
- 1Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria, Australia and
| | - Michael D. Tavaria
- 1Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria, Australia and
| | - Kym L. Stanley
- 1Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria, Australia and
| | - Erica K. Sloan
- 1Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria, Australia and
| | - Jane M. Moseley
- 2Department of Medicine, University of Melbourne, St. Vincent's Hospital, Fitzroy, Victoria, Australia
| | - Robin L. Anderson
- 1Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria, Australia and
| |
Collapse
|
2
|
Sloan EK, Stanley KL, Anderson RL. Caveolin-1 inhibits breast cancer growth and metastasis. Oncogene 2004; 23:7893-7. [PMID: 15334058 DOI: 10.1038/sj.onc.1208062] [Citation(s) in RCA: 119] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Caveolin-1 was identified in a screen for genes involved in breast cancer progression. Caveolin-1 is the major protein component of caveolae, flask-shaped invaginations found in a number of different cell types. Using an orthotopic model of spontaneous breast cancer metastasis, caveolin-1 was found to be expressed in low and non-metastatic primary tumors, but at much lower levels in highly metastatic 4T1.2 and 4T1.13 tumors. Exogenous expression of caveolin-1 at moderate levels in 4T1.2 cells was sufficient to suppress primary tumor growth after inoculation of cells into the mammary gland. Expression of high levels of caveolin-1 also inhibited subsequent metastasis to distant organs. Cells expressing high levels of caveolin-1 showed reduced capacity to invade Matrigel, diminished response to laminin-1 stimulation and decreased metastasis to lung and bone. This study provides the first functional evidence that caveolin-1 regulates primary breast tumor growth and spontaneous metastasis of breast cancer.
Collapse
Affiliation(s)
- Erica K Sloan
- Peter MacCallum Cancer Centre, Locked Bag #1, A'Beckett Street, Melbourne, Victoria 8006, Australia
| | | | | |
Collapse
|